These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 16580634)

  • 1. The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1.
    Setogawa T; Shinozaki-Yabana S; Masuda T; Matsuura K; Akiyama T
    Biochem Biophys Res Commun; 2006 May; 343(4):1186-90. PubMed ID: 16580634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
    Zeng PY; Berger SL
    Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LKB1 catalytically deficient mutants enhance cyclin D1 expression.
    Scott KD; Nath-Sain S; Agnew MD; Marignani PA
    Cancer Res; 2007 Jun; 67(12):5622-7. PubMed ID: 17575127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients.
    Boudeau J; Kieloch A; Alessi DR; Stella A; Guanti G; Resta N
    Hum Mutat; 2003 Feb; 21(2):172. PubMed ID: 12552571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
    Upadhyay S; Liu C; Chatterjee A; Hoque MO; Kim MS; Engles J; Westra W; Trink B; Ratovitski E; Sidransky D
    Cancer Res; 2006 Aug; 66(16):7870-9. PubMed ID: 16912160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
    Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
    Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.
    Fernandez P; Carretero J; Medina PP; Jimenez AI; Rodriguez-Perales S; Paz MF; Cigudosa JC; Esteller M; Lombardia L; Morente M; Sanchez-Verde L; Sotelo T; Sanchez-Cespedes M
    Oncogene; 2004 Jun; 23(29):5084-91. PubMed ID: 15077168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.
    Suzuki H; Kurita M; Mizumoto K; Moriyama M; Aiso S; Nishimoto I; Matsuoka M
    Biochem Biophys Res Commun; 2005 Jan; 326(1):242-8. PubMed ID: 15567177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
    Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
    Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4.
    Deane JE; Mackay JP; Kwan AH; Sum EY; Visvader JE; Matthews JM
    EMBO J; 2003 May; 22(9):2224-33. PubMed ID: 12727888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
    Rodriguez-Nieto S; Sanchez-Cespedes M
    Carcinogenesis; 2009 Apr; 30(4):547-54. PubMed ID: 19176640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LKB1; linking cell structure and tumor suppression.
    Hezel AF; Bardeesy N
    Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.
    Choi BH; Kim CG; Bae YS; Lim Y; Lee YH; Shin SY
    Cancer Res; 2008 Mar; 68(5):1369-77. PubMed ID: 18316600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.
    Carretero J; Medina PP; Pio R; Montuenga LM; Sanchez-Cespedes M
    Oncogene; 2004 May; 23(22):4037-40. PubMed ID: 15021901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential.
    Zhuang ZG; Di GH; Shen ZZ; Ding J; Shao ZM
    Mol Cancer Res; 2006 Nov; 4(11):843-9. PubMed ID: 17114342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.
    Soto-Cerrato V; Viñals F; Lambert JR; Pérez-Tomás R
    Biochem Pharmacol; 2007 Nov; 74(9):1340-9. PubMed ID: 17765876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Ras upregulates NADPH oxidase 1 gene expression through MEK-ERK-dependent phosphorylation of GATA-6.
    Adachi Y; Shibai Y; Mitsushita J; Shang WH; Hirose K; Kamata T
    Oncogene; 2008 Aug; 27(36):4921-32. PubMed ID: 18454176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.